Dermovate Ointment 0.05% (Clobetasol Propionate)

What is Dermovate Ointment 0.05% (Clobetasol Propionate)?

A very strong steroid cream used to treat severe inflammatory skin conditions that do respond well to weaker steroids. 

It helps to reduce swelling, itching and redness caused by a range of skin conditions including:

• Psoriasis (excluding widespread plaque psoriasis)
• Eczema (severe cases)
• Lichen planus
• Lupus erythematosus (discoid type)
• Other severe inflammatory dermatoses
• Dermatitis that has not responded to milder treatments

Also Available;

Buy Dermovate Cream 0.05% here

Ingredients

The active ingredient is clobetasol propionate. Each 1 g contains 0.5 mg of clobetasol propionate (0.05% w/w).

The other ingredients are propylene glycol (see section 2), sorbitan sesquioleate and white soft paraffin.

Apply a thin layer to the affected area once or twice daily.

Do not use for more than 2 weeks continuously unless advised by a doctor.

Avoid applying to broken skin, face, or large areas unless prescribed.

Do not cover with bandages unless directed by a healthcare professional.

You can download a copy of the dermovate patient information leaflet here.

Precautions:

• Not for long-term use due to risk of side effects.
• Avoid contact with eyes, mouth, and mucous membranes.
• Not recommended for children under 12 unless prescribed.
• Use with caution in pregnant or breastfeeding women.

Warnings and precautions

Talk to your doctor or pharmacist before using Dermovate if:

• you experience newly developed bone pain or worsening of previous bone symptoms during a treatment with Dermovate especially if you have been using Dermovate for a prolonged time or repeatedly.
• you use other oral/topical medication containing corticosteroids or medication intended to control your immune system (e.g. for autoimmune disease or after a transplantation).

Combining Dermovate with these medicines may result in serious infections.

• you have previously had an allergic reaction with another steroid
• you are applying the ointment under an airtight dressing, including a child’s nappy. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much ointment.

Make sure that the skin is cleansed before a fresh dressing is applied to prevent infections.

• you are applying the ointment on broken or damaged skin or within the skin folds.
• you are applying to a large surface area.
• you have psoriasis, your doctor will want to see you more often.
• you are using around a chronic leg ulcer as you may be at increased risk of local allergic reaction or infection.
• you are applying near eyes or on eyelids, as cataracts or glaucoma may result if the ointment repeatedly enters the eye.
• you are applying to thin skin such as the face, as Dermovate may cause skin thinning.

Use on the face should be limited to 5 days.

Dressings or bandages should not be used on the face where the ointment is applied.

If an infection develops during the use of this medicine, talk to your doctor or pharmacist.

Contact your doctor if you experience blurred vision or other visual disturbances.

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine.

If there is a worsening of your condition during use consult your prescriber – you may be experiencing an allergic reaction, have an infection or your condition requires a different treatment.

If you experience a recurrence of your condition shortly after stopping treatment, within 2 weeks, do not restart using the cream/ointment without consulting your prescriber unless your prescriber has previously advised you to so.

If your condition has resolved and on recurrence the redness extends beyond the initial treatment area and you experience a burning sensation, please seek medical advice before restarting treatment.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the above description and patient information leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for “MHRA yellowcard” in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.